Streetbeat News

Assets

RMCO

Royalty Management Holding Corporation (NASDAQ:RMCO) is expanding its environmental surety bond business, which provides long-term revenue through bonding premiums and fees. The company is also exploring additional acquisitions in the environmental surety sector to accelerate growth. RMCO's strategy focuses on responsible resource extraction and environmental protection, aiming to generate positive returns for shareholders and stakeholders.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:37 pm

INBS

Intelligent Bio Solutions (INBS) has announced a private placement priced at-the-market under Nasdaq rules, raising $10.1 million. This move could indicate the company's strategy for growth or financial restructuring.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:34 pm

ROST

Ross Stores, Inc. has opened 18 new stores across 11 states, including 11 Ross Dress for Less and seven dd's DISCOUNTS locations. This expansion is part of their plan to open approximately 90 new stores in fiscal 2024, aiming for a total of 75 Ross and 15 dd's DISCOUNTS stores. The company now operates 2,127 locations nationwide and has a long-term goal of reaching 2,900 Ross and 700 dd's DISCOUNTS stores, driven by consumer demand for value and convenience.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:33 pm

BTCUSD

ETHUSD

A trader predicts Bitcoin could reach $89,000 soon if it closes above $73,000 today, citing USDT minting and ETF inflows as positive signs. The UK's Financial Conduct Authority's decision to allow cryptocurrency-linked ETP filings and the upcoming Bitcoin halving event are also seen as bullish indicators. Ethereum also saw gains, crossing the $4,040 mark.

Portfolio Pulse from Murtuza Merchant

March 11, 2024 | 12:32 pm

FXI

SPY

China has requested banks to increase financing support for the state-backed real estate giant, China Vanke, and urged creditors to consider extending the maturity of private debt, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:20 pm

BIOR

Biora Therapeutics has successfully reduced its net debt and monetized a legacy asset by selling a minority stake to Enumera Investors for $3 million, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:15 pm

MSTR

MicroStrategy Inc. (NASDAQ:MSTR) has successfully raised $800 million through the sale of convertible notes, with plans to use the funds to purchase more Bitcoin. The notes, bearing a low interest rate of 0.625% per year, are set to mature on March 15, 2030, unless converted into stock earlier. This move comes as Bitcoin's price surpassed the $70,000 mark. Following the announcement, MSTR's stock price surged 8.59% to $1,548 before market open.

Portfolio Pulse from Benzinga Neuro

March 11, 2024 | 12:13 pm

ACA

NOV

Arcosa, Inc. (ACA) has announced an agreement to acquire Ameron Pole Products from NOV Inc. (NOV) for $180 million in cash. This acquisition is aimed at expanding Arcosa's presence in the infrastructure market, specifically in the concrete and steel pole lighting sector, as well as in traffic and telecommunication structures. Ameron, with revenues of approximately $94 million and an Adjusted EBITDA of $20 million for the year ended December 31, 2023, strengthens Arcosa's Engineered Structures segment. The purchase will be funded through cash and available revolver capacity, with the transaction expected to close in the second quarter of 2024.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:09 pm

BIOR

Biora Therapeutics, Inc. (NASDAQ:BIOR) has announced a series of financial transactions aimed at reducing its net debt and raising new capital. The company has exchanged convertible notes for new capital and senior secured notes, bringing in $2.8 million. Additionally, Biora has monetized its investment in Enumera Molecular, Inc., resulting in $3 million of nondilutive funding. These transactions are part of Biora's efforts to optimize its capital structure and fund its therapeutic programs. The company has reduced its debt by over $80 million since September 2023 through note exchange transactions, with institutional investors contributing $19.8 million of new capital.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:02 pm

BIVI

BioVie announced the completion of a funding round aimed at advancing its clinical priorities in Parkinson's Disease, Alzheimer's Disease, and Ascites/Liver Disease. The company is also exploring longevity and aging with partners.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:02 pm